FBInvestor
Funds / Hillman Capital Management, Inc.
Institutional Fund

Hillman Capital Management, Inc.

Bethesda, MDCIK 13146205 filings on record

Portfolio Value
$144.00M
Q1 2026
Holdings
56
Reported positions
New Buys
6
Opened this quarter
QoQ Change
-9.4%
from $158.91M

Portfolio Value Trend

Reported 13F value by quarter

Portfolio value trend — upgrade to see history

Upgrade

Top Allocations

Largest positions by weight

  • Biogen Inc3.8%
  • Dupont De Nemours Inc3.7%
  • Warner Bros Discovery Inc3.7%
  • Gsk PLC3.7%
  • International Flavors&Fragra3.7%
  • Pfizer Inc3.7%
  • Other77.7%

Portfolio Holdings

56 positions · Q1 2026

#SecuritySharesValue% Port.Δ SharesActivity
1Biogen Inc29.5K$5.42M3.8%976Reduced
2Dupont De Nemours Inc117.9K$5.40M3.7%15.3KReduced
3Warner Bros Discovery Inc196.3K$5.39M3.7%18.3KReduced
4Gsk PLC97.4K$5.38M3.7%16.9KReduced
5International Flavors&Fragra72.8K$5.28M3.7%3.3KReduced
6Pfizer Inc187.9K$5.28M3.7%+12.6KAdded
7Zimmer Biomet Holdings Inc55.7K$5.04M3.5%+9.7KAdded
8Cvs Health Corp67.5K$4.85M3.4%4.2KReduced
9Brown Forman Corp176.4K$4.66M3.2%+28.4KAdded
10Carmax Inc109.2K$4.54M3.2%1.9KReduced

46 more holdings on Premium

See this fund's complete portfolio, full position changes, and activity history.

Unlock full portfolio